JP2013514971A5 - - Google Patents

Download PDF

Info

Publication number
JP2013514971A5
JP2013514971A5 JP2012543843A JP2012543843A JP2013514971A5 JP 2013514971 A5 JP2013514971 A5 JP 2013514971A5 JP 2012543843 A JP2012543843 A JP 2012543843A JP 2012543843 A JP2012543843 A JP 2012543843A JP 2013514971 A5 JP2013514971 A5 JP 2013514971A5
Authority
JP
Japan
Prior art keywords
microparticles
implant
poly
lactide
polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012543843A
Other languages
English (en)
Japanese (ja)
Other versions
JP5950825B2 (ja
JP2013514971A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2010/070246 external-priority patent/WO2011080141A2/en
Publication of JP2013514971A publication Critical patent/JP2013514971A/ja
Publication of JP2013514971A5 publication Critical patent/JP2013514971A5/ja
Application granted granted Critical
Publication of JP5950825B2 publication Critical patent/JP5950825B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012543843A 2009-12-21 2010-12-20 活性化合物の持続放出のための分解性の取り外し可能なインプラント Active JP5950825B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28837309P 2009-12-21 2009-12-21
US61/288,373 2009-12-21
PCT/EP2010/070246 WO2011080141A2 (en) 2009-12-21 2010-12-20 Degradable removable implant for the sustained release of an active compound

Publications (3)

Publication Number Publication Date
JP2013514971A JP2013514971A (ja) 2013-05-02
JP2013514971A5 true JP2013514971A5 (enExample) 2014-02-13
JP5950825B2 JP5950825B2 (ja) 2016-07-13

Family

ID=43743502

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012543843A Active JP5950825B2 (ja) 2009-12-21 2010-12-20 活性化合物の持続放出のための分解性の取り外し可能なインプラント

Country Status (18)

Country Link
US (3) US8784858B2 (enExample)
EP (1) EP2515877B1 (enExample)
JP (1) JP5950825B2 (enExample)
KR (1) KR101798430B1 (enExample)
CN (1) CN102740837B (enExample)
AU (1) AU2010338425B2 (enExample)
BR (1) BR112012015114B1 (enExample)
CA (1) CA2784530C (enExample)
ES (1) ES2600878T3 (enExample)
IL (1) IL219685B (enExample)
MX (1) MX2012007210A (enExample)
MY (1) MY163383A (enExample)
NZ (1) NZ600156A (enExample)
RU (1) RU2593790C2 (enExample)
SG (1) SG181759A1 (enExample)
UA (1) UA112155C2 (enExample)
WO (1) WO2011080141A2 (enExample)
ZA (1) ZA201204583B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3011383A4 (en) * 2013-06-20 2016-11-30 Mercy Medical Res Inst CONTACT LENSES WITH DELAYED ACTIVE COMPOSITION AND METHOD OF MANUFACTURING
AU2015301432B2 (en) 2014-08-15 2019-11-21 The Johns Hopkins University Composite material for tissue restoration
WO2016149561A1 (en) * 2015-03-17 2016-09-22 Oak Crest Institute Of Science Subdermal implants for the sustained delivery of water-soluble drugs
US11779435B2 (en) 2015-08-26 2023-10-10 Flexscrewdriver I.K.E. Dental screwdriver
CN106702597B (zh) * 2016-12-20 2019-06-18 华南理工大学 一种核-壳结构纳米纤维膜及其制备方法和应用
EP3651800B1 (en) * 2017-07-11 2024-04-10 Sustained Nano Systems LLC Hypercompressed pharmaceutical formulations
CN112384258A (zh) 2018-05-09 2021-02-19 约翰·霍普金斯大学 用于细胞和组织递送的纳米纤维-水凝胶复合物
IL307979B2 (en) 2018-05-09 2025-08-01 Univ Johns Hopkins Nanofiber-hydrogel composites for enhanced soft tissue replacement and regeneration
WO2019222482A1 (en) * 2018-05-16 2019-11-21 Spirox, Inc. Allergic rhinitis drug delivery implant
AU2019362880B2 (en) * 2018-10-16 2025-05-22 Research Triangle Institute Subcutaneous biodegradable reservoir device
US20230165788A1 (en) * 2020-04-07 2023-06-01 Research Triangle Institute Multi-drug formulations for subcutaneous biodegradable reservoir device
EP4151673A4 (en) * 2020-05-12 2024-03-20 Laboratorios Farmacéuticos Rovi, S.A. METHOD FOR THE PURIFICATION OF BIODEGRADABLE THERMOPLASTIC POLYMER PARTICLES FOR MEDICAL AND/OR PHARMACEUTICAL USE

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5182111A (en) * 1987-11-17 1993-01-26 Boston University Research Foundation In vivo delivery of active factors by co-cultured cell implants
WO1993009176A2 (en) * 1991-10-29 1993-05-13 Clover Consolidated, Limited Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release
US5645684A (en) 1994-03-07 1997-07-08 The Regents Of The University Of California Multilayer high vertical aspect ratio thin film structures
US5798042A (en) 1994-03-07 1998-08-25 Regents Of The University Of California Microfabricated filter with specially constructed channel walls, and containment well and capsule constructed with such filters
US5660680A (en) 1994-03-07 1997-08-26 The Regents Of The University Of California Method for fabrication of high vertical aspect ratio thin film structures
US5651900A (en) 1994-03-07 1997-07-29 The Regents Of The University Of California Microfabricated particle filter
AU1979995A (en) 1994-03-07 1995-09-25 Regents Of The University Of California, The Microfabricated capsules for isolation of cell transplants
US7033603B2 (en) * 1999-08-06 2006-04-25 Board Of Regents The University Of Texas Drug releasing biodegradable fiber for delivery of therapeutics
AU6526100A (en) 1999-08-06 2001-03-05 Board Of Regents, The University Of Texas System Drug releasing biodegradable fiber implant
IL149005A0 (en) 1999-10-06 2002-11-10 Us Gov Health & Human Serv Hexahydrofuro-2', 3-bifuran-3-yl-n-{3'(1, 3-benzodioxol-5-ylsulfonyl) (isobutyl) amino-1-benzyl-2-hydroxypropyl} carbamate as restroviral protease inhibitor
TW200800298A (en) 2000-01-27 2008-01-01 Zentaris Ag Compressed microparticles for dry injection
US20040115268A1 (en) 2000-04-26 2004-06-17 Control Delivery Systems, Inc. Systemic delivery of antiviral agents
DE10050199A1 (de) * 2000-10-11 2002-04-25 Ethicon Gmbh Flächiges Implantat mit im Ultraschall detektierbaren Elementen
EP1387670B1 (en) * 2001-05-11 2008-10-15 Ortho-McNeil-Janssen Pharmaceuticals, Inc. Immune modulation device for use in animals
MY169670A (en) 2003-09-03 2019-05-08 Tibotec Pharm Ltd Combinations of a pyrimidine containing nnrti with rt inhibitors
US7497855B2 (en) 2002-09-04 2009-03-03 Microchips, Inc. Method and device for the controlled delivery of parathyroid hormone
US20040156878A1 (en) * 2003-02-11 2004-08-12 Alireza Rezania Implantable medical device seeded with mammalian cells and methods of treatment
TWI457136B (zh) * 2005-04-04 2014-10-21 Tibotec Pharm Ltd Hiv-感染之預防
AU2006235565A1 (en) 2005-04-11 2006-10-19 The Board Of Trustees Of The Leland Stanford Junior University Multi-layer structure having a predetermined layer pattern including an agent
US20060252049A1 (en) 2005-05-04 2006-11-09 Shuler Richard O Growth-promoting and immunizing subcutaneous implant
US7261529B2 (en) 2005-09-07 2007-08-28 Southwest Research Institute Apparatus for preparing biodegradable microparticle formulations containing pharmaceutically active agents
SI1981506T1 (sl) * 2006-01-20 2013-08-30 Janssen R&D Ireland Dolgoročno zdravljenje infekcije HIV s TCM278
WO2008060360A2 (en) * 2006-09-28 2008-05-22 Surmodics, Inc. Implantable medical device with apertures for delivery of bioactive agents
SI2003120T1 (sl) * 2007-06-12 2010-03-31 Concert Pharmaceuticals Inc Azapeptidni derivati kot inhibitorji hiv proteaze
US20090123508A1 (en) 2007-10-04 2009-05-14 Boston Scientific Scimed, Inc. Implantable Drug Depot for Intrathecal Drug Delivery System for Pain Management
US20110257111A1 (en) * 2008-10-24 2011-10-20 Harbeson Scott L Hydroxyethlamino Sulfonamide Derivatives
SG172398A1 (en) 2008-12-24 2011-07-28 Tibotec Pharm Ltd Implantable devices for treating hiv

Similar Documents

Publication Publication Date Title
JP2013514971A5 (enExample)
RU2012131282A (ru) Разлагаемый удаляемый имплантат для непрерывного высвобождения активного соединения
JP2014504170A5 (enExample)
JP2013529507A5 (enExample)
JP2013212418A5 (enExample)
MX351986B (es) Composiciones polimericas bioabsorbibles, metodos de procesamiento y dispositivos medicos de estas.
JP6343031B2 (ja) 高性能高分子量ポリl−乳酸合成プロセス
WO2008127889A3 (en) Degradable polymers incorporating gamma- butyrolactone
ES2703735T3 (es) Copolímeros de diglicolato de polietileno absorbibles para reducir la adhesión microbiana a dispositivos médicos e implantes
US20070299155A1 (en) Biodegradable polymer adhesion barriers
WO2005112587A3 (en) Wound healing polymer compositions and methods for use thereof
JP2012514121A5 (enExample)
JP2017527341A5 (enExample)
JP2010514474A5 (enExample)
EP2079491A2 (en) N-substituted monomers and polymers
JP2011508791A5 (enExample)
JP2010534513A5 (enExample)
JP2020523303A5 (enExample)
JP4899152B2 (ja) 医療用樹脂組成物とその製造方法および成形体
JPWO2016114216A1 (ja) 生分解性ステント
US20200108182A1 (en) Self-expandable stent and method of producing the same
van Dijkhuizen-Radersma et al. Degradable polymers for tissue engineering
Jelonek et al. Polyesters and polyestercarbonates for controlled drug delivery Part I. Tailoring of the drug release
JP2010528766A5 (enExample)
JP2016515563A5 (enExample)